Pages that link to "Q28189659"
Jump to navigation
Jump to search
The following pages link to Characterization of 4 mantle cell lymphoma cell lines (Q28189659):
Displaying 50 items.
- Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma (Q24312127) (← links)
- Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma (Q24655119) (← links)
- Crystal structure of human CDK4 in complex with a D-type cyclin (Q24656160) (← links)
- MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management (Q26785379) (← links)
- Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors (Q27684150) (← links)
- Blockade of fatty acid synthase triggers significant apoptosis in mantle cell lymphoma (Q28730808) (← links)
- The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo (Q28751751) (← links)
- Integrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasms (Q31077729) (← links)
- High expression of Mcl-1 in ALK positive and negative anaplastic large cell lymphoma (Q31164878) (← links)
- Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1 (Q33798463) (← links)
- Degrasyn potentiates the antitumor effects of bortezomib in mantle cell lymphoma cells in vitro and in vivo: therapeutic implications (Q33832937) (← links)
- Knock‐down of SOX11 induces autotaxin‐dependent increase in proliferation in vitro and more aggressive tumors in vivo (Q34006685) (← links)
- Responses in Mantle Cell Lymphoma Cells to SNS-032 Depend on the Biological Context of Each Cell Line (Q34091061) (← links)
- Herpes simplex virus 1 mutant in which the ICP0 HUL-1 E3 ubiquitin ligase site is disrupted stabilizes cdc34 but degrades D-type cyclins and exhibits diminished neurotoxicity (Q34227708) (← links)
- FTY720 shows promising in vitro and in vivo preclinical activity by downmodulating Cyclin D1 and phospho-Akt in mantle cell lymphoma (Q34269804) (← links)
- Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma (Q34328140) (← links)
- Expression and effects of inhibition of type I insulin-like growth factor receptor tyrosine kinase in mantle cell lymphoma. (Q35018535) (← links)
- Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors. (Q35235267) (← links)
- Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185. (Q35764599) (← links)
- Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia (Q36170317) (← links)
- Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma (Q36772172) (← links)
- Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol. (Q36914970) (← links)
- Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma (Q37273485) (← links)
- Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing. (Q37368735) (← links)
- Preclinical activity of 8-chloroadenosine with mantle cell lymphoma: roles of energy depletion and inhibition of DNA and RNA synthesis (Q37424558) (← links)
- Mantle cell lymphoma in cyclin D1 transgenic mice with Bim-deficient B cells (Q37564773) (← links)
- A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma (Q37600907) (← links)
- Combination of Pim kinase inhibitor SGI-1776 and bendamustine in B-cell lymphoma (Q38260135) (← links)
- B cell receptor signaling regulates metabolism in Chronic Lymphocytic Leukemia (Q38611244) (← links)
- Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma (Q38740003) (← links)
- Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors (Q38832541) (← links)
- Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease (Q39017105) (← links)
- Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphoma (Q39283981) (← links)
- Essential role of TAK1 in regulating mantle cell lymphoma survival. (Q39339382) (← links)
- PRDM1 is required for mantle cell lymphoma response to bortezomib (Q39695887) (← links)
- All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma (Q39699466) (← links)
- Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy (Q39882401) (← links)
- MDM2 antagonist nutlin-3 displays antiproliferative and proapoptotic activity in mantle cell lymphoma. (Q39888339) (← links)
- Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma (Q40200306) (← links)
- Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. (Q40280853) (← links)
- The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers. (Q41116766) (← links)
- Interleukin 22 Signaling Promotes Cell Growth in Mantle Cell Lymphoma (Q42580235) (← links)
- Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma (Q42928100) (← links)
- Inhibition of O-GlcNAcase sensitizes apoptosis and reverses bortezomib resistance in mantle cell lymphoma through modification of truncated Bid. (Q45073732) (← links)
- Gene-body hypermethylation controlled cryptic promoter and miR26A1-dependent EZH2 regulation of TET1 gene activity in chronic lymphocytic leukemia (Q47134267) (← links)
- Cyclin D1 depletion induces DNA damage in mantle cell lymphoma lines (Q47615901) (← links)
- Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma (Q51682819) (← links)
- Granta-519 (Q54871671) (← links)
- JeKo-1 (Q54898569) (← links)
- Mino (Q54905748) (← links)